Juni 2012 - IOZK

Immunotherapies for non-small-cell lung cancer and mesothelioma

2012-06-28/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-06-28 / Lancet Oncol. 2012 Jul;13(7):e301-10

Old and new facts about hyperthermia-induced modulations of the immune system

2012-06-12/in Hyperthermia, International Publications /von 2012-06-12 / Int J Hyperthermia 2012;28(6):528-42

Neoadjuvant chemotherapy followed by radiotherapy and concurrent hyperthermia in patients with advanced-stage cervical cancer: a retrospective study

2012-06-12/in Cervical Cancer, Hyperthermia, International Publications /von 2012-06-12 / Int J Hyperthermia 2012;28(6):554-61

Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.

2012-06-04/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2546)

Autologous dendritic cell vaccine (ADCV) in combination with plasmapheresis (PP) and cyclophosphamide (Cy) in patients with disseminated melanoma: A phase II study.

2012-06-04/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr e13059)

WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.

2012-06-04/in Acute Leukemia, Dendritic Cells, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2506)

The final report of a phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with glioblastoma.

2012-06-02/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2084)

Correlation of survival with tumor antigen expression in patients with newly diagnosed glioblastoma receiving a multi-epitope pulsed dendritic cell vaccine.

2012-06-02/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2087)

CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.

2012-06-02/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2525)

Adjuvant dendritic cell (DC)-based vaccine therapy of melanoma patients.

2012-06-02/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2524)